HRT Financial’s Cingulate CING Stock Holding History

HRT Financial’s Portfolio CING Stock Details CING Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$205K	Buy	+33,144	New	+$212K	﹤0.01%	3185
2024 Q2	–	Sell	-891	Closed	-$11K	–	2323
2024 Q1	$11K	Buy	+891	New	+$28.6K	﹤0.01%	2057

Other funds holding CING

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

BAM

BCV Asset Management Winnipeg $2.91B AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HRT Financial's CING Position: Q1 2026 in Review

HRT Financial opened a new position in Cingulate (CING) in Q1 2026: 33,144 shares worth $205K. The stake represents ﹤0.01% of the portfolio and ranks #3185 among its holdings. This is a return to the name: HRT Financial previously reported a position in CING as recently as Q1 2024.

HRT Financial first reported a position in CING in Q1 2024 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold CING as of Q1 2026.

HRT Financial held 33,144 shares of Cingulate worth $205K as of Q1 2026.
Cingulate was a new HRT Financial position in Q1 2026.
Cingulate made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3185 holding.
HRT Financial first reported a position in Cingulate in Q1 2024 and has held it in 2 quarters since.
27 funds tracked by Wall St. Rank held Cingulate as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.